These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 17586867

  • 1. Patterns of levodopa response in Parkinson's disease: a clinico-pathological study.
    Kempster PA, Williams DR, Selikhova M, Holton J, Revesz T, Lees AJ.
    Brain; 2007 Aug; 130(Pt 8):2123-8. PubMed ID: 17586867
    [Abstract] [Full Text] [Related]

  • 2. Relationships between age and late progression of Parkinson's disease: a clinico-pathological study.
    Kempster PA, O'Sullivan SS, Holton JL, Revesz T, Lees AJ.
    Brain; 2010 Jun; 133(Pt 6):1755-62. PubMed ID: 20371510
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Profiling the most elderly parkinson's disease patients: Does age or disease duration matter?
    Virameteekul S, Phokaewvarangkul O, Bhidayasiri R.
    PLoS One; 2021 Jun; 16(12):e0261302. PubMed ID: 34937068
    [Abstract] [Full Text] [Related]

  • 5. Natural history of motor symptoms in Parkinson's disease and the long-duration response to levodopa.
    Cilia R, Cereda E, Akpalu A, Sarfo FS, Cham M, Laryea R, Obese V, Oppon K, Del Sorbo F, Bonvegna S, Zecchinelli AL, Pezzoli G.
    Brain; 2020 Aug 01; 143(8):2490-2501. PubMed ID: 32844196
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies.
    Molloy SA, Rowan EN, O'Brien JT, McKeith IG, Wesnes K, Burn DJ.
    J Neurol Neurosurg Psychiatry; 2006 Dec 01; 77(12):1323-8. PubMed ID: 16952917
    [Abstract] [Full Text] [Related]

  • 8. Testing an aetiological model of visual hallucinations in Parkinson's disease.
    Gallagher DA, Parkkinen L, O'Sullivan SS, Spratt A, Shah A, Davey CC, Bremner FD, Revesz T, Williams DR, Lees AJ, Schrag A.
    Brain; 2011 Nov 01; 134(Pt 11):3299-309. PubMed ID: 21921019
    [Abstract] [Full Text] [Related]

  • 9. Motor response to acute dopaminergic challenge with apomorphine and levodopa in Parkinson's disease: implications for the pathogenesis of the on-off phenomenon.
    Colosimo C, Merello M, Hughes AJ, Sieradzan K, Lees AJ.
    J Neurol Neurosurg Psychiatry; 1996 Jun 01; 60(6):634-7. PubMed ID: 8648329
    [Abstract] [Full Text] [Related]

  • 10. Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response.
    Apaydin H, Ahlskog JE, Parisi JE, Boeve BF, Dickson DW.
    Arch Neurol; 2002 Jan 01; 59(1):102-12. PubMed ID: 11790237
    [Abstract] [Full Text] [Related]

  • 11. Longitudinal study of levodopa in Parkinson's disease: effects of the advanced disease phase.
    Ganga G, Alty JE, Clissold BG, McColl CD, Reardon KA, Schiff M, Kempster PA.
    Mov Disord; 2013 Apr 01; 28(4):476-81. PubMed ID: 23390112
    [Abstract] [Full Text] [Related]

  • 12. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D, Bosboom JL, Deijen JB, Wolters EC, Berendse HW, Stam CJ.
    Brain; 2007 Jul 01; 130(Pt 7):1847-60. PubMed ID: 17412733
    [Abstract] [Full Text] [Related]

  • 13. [11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease.
    Kumar A, Mann S, Sossi V, Ruth TJ, Stoessl AJ, Schulzer M, Lee CS.
    Brain; 2003 Dec 01; 126(Pt 12):2648-55. PubMed ID: 12937076
    [Abstract] [Full Text] [Related]

  • 14. Clinical-pathological study of levodopa complications.
    Rajput AH, Fenton ME, Birdi S, Macaulay R, George D, Rozdilsky B, Ang LC, Senthilselvan A, Hornykiewicz O.
    Mov Disord; 2002 Mar 01; 17(2):289-96. PubMed ID: 11921114
    [Abstract] [Full Text] [Related]

  • 15. Response of non-motor symptoms to levodopa in late-stage Parkinson's disease: Results of a levodopa challenge test.
    Fabbri M, Coelho M, Guedes LC, Chendo I, Sousa C, Rosa MM, Abreu D, Costa N, Godinho C, Antonini A, Ferreira JJ.
    Parkinsonism Relat Disord; 2017 Jun 01; 39():37-43. PubMed ID: 28389156
    [Abstract] [Full Text] [Related]

  • 16. Does levodopa slow or hasten the rate of progression of Parkinson's disease?
    Fahn S, Parkinson Study Group.
    J Neurol; 2005 Oct 01; 252 Suppl 4():IV37-IV42. PubMed ID: 16222436
    [Abstract] [Full Text] [Related]

  • 17. Clinical and pharmacological differences in early- versus late-onset Parkinson's disease.
    Gomez Arevalo G, Jorge R, Garcia S, Scipioni O, Gershanik O.
    Mov Disord; 1997 May 01; 12(3):277-84. PubMed ID: 9159719
    [Abstract] [Full Text] [Related]

  • 18. Effect of late initiation of levodopa treatment in patients with long-standing Parkinson's disease.
    Djaldetti R, Treves TA, Merims D, Sroka H, Melamed E.
    Clin Neuropharmacol; 2003 May 01; 26(1):24-7. PubMed ID: 12567161
    [Abstract] [Full Text] [Related]

  • 19. Motor fluctuations in Parkinson's disease.
    Denny AP, Behari M.
    J Neurol Sci; 1999 May 01; 165(1):18-23. PubMed ID: 10426141
    [Abstract] [Full Text] [Related]

  • 20. Levodopa Effect and Motor Function in Late Stage Parkinson's Disease.
    Rosqvist K, Horne M, Hagell P, Iwarsson S, Nilsson MH, Odin P.
    J Parkinsons Dis; 2018 May 01; 8(1):59-70. PubMed ID: 29480220
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.